Results 231 to 240 of about 72,117 (255)
Some of the next articles are maybe not open access.
Innovations in the Use of Antisense Oligonucleotides
Annals of the New York Academy of Sciences, 1990The use of antisense oligonucleotides for controlling genetic expression has recently received widespread attention, especially as a new class of potential chemotherapeutic agents. This coupled with the urgency of developing new effective therapies for acquired immunodeficiency syndrome (AIDS) has led to various antisense studies dealing with human ...
openaire +2 more sources
Antisense oligonucleotide strategies in physiology
Molecular and Cellular Endocrinology, 1994Antisense oligonucleotides can inhibit gene expression in living cells by binding to complementary sequences of DNA, RNA or mRNA. The mechanisms include inhibition of RNA synthesis, RNA splicing, mRNA export, binding of initiation factors, assembly of ribosome subunits and of sliding of the ribosome along the mRNA coding sequence.
openaire +2 more sources
Antisense oligonucleotides as therapeutics for hyperlipidaemias
Expert Opinion on Biological Therapy, 2005Hyperlipidaemia, due to elevations of low-density lipoprotein cholesterol (LDL-C) or triglycerides (TGs), is recognised as a significant risk factor contributing to the development of coronary heart disease (CHD), the leading cause of morbidity and mortality in the Western world.
openaire +2 more sources
Antisense Oligonucleotides as Antiviral Agentsa
Annals of the New York Academy of Sciences, 1992J, Coulson, A D, Malcolm
openaire +3 more sources
Antisense oligonucleotide therapeutics
Expert Opinion on Investigational Drugs, 1999openaire +2 more sources
Review on investigations of antisense oligonucleotides with the use of mass spectrometry
Talanta, 2018Sylwia Studzinska
exaly
Antisense oligonucleotides: a new therapeutic principle
Chemical Reviews, 1990Eugen Uhlmann, A Peyman
exaly
Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice
Nucleic Acids Research, 2018Peter H Hagedorn +2 more
exaly

